Dagmar Scheel‐Toellner

7.3k total citations · 2 hit papers
63 papers, 5.4k citations indexed

About

Dagmar Scheel‐Toellner is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Dagmar Scheel‐Toellner has authored 63 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 19 papers in Molecular Biology and 17 papers in Rheumatology. Recurrent topics in Dagmar Scheel‐Toellner's work include T-cell and B-cell Immunology (15 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Cell death mechanisms and regulation (11 papers). Dagmar Scheel‐Toellner is often cited by papers focused on T-cell and B-cell Immunology (15 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Cell death mechanisms and regulation (11 papers). Dagmar Scheel‐Toellner collaborates with scholars based in United Kingdom, Germany and United States. Dagmar Scheel‐Toellner's co-authors include Janet M. Lord, Christopher D. Buckley, Mike Salmon, Darrell Pilling, Arne N. Akbar, N. Henriquez, Karim Raza, Elizabeth M. Deacon, M Salmon and Andrew Filer and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Dagmar Scheel‐Toellner

62 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serine/Threonine Protein Kinases and Apoptosis

2000 606 citations Dagmar Scheel‐Toellner, N. Henriquez et al. Experimental Cell Research profile →
Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation

2001 559 citations Christopher D. Buckley, Darrell Pilling et al. Trends in Immunology profile →

Peers

Countries citing papers authored by Dagmar Scheel‐Toellner

Since Specialization

Citations

This map shows the geographic impact of Dagmar Scheel‐Toellner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Scheel‐Toellner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Scheel‐Toellner more than expected).

Fields of papers citing papers by Dagmar Scheel‐Toellner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Scheel‐Toellner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Scheel‐Toellner. The network helps show where Dagmar Scheel‐Toellner may publish in the future.

Co-authorship network of co-authors of Dagmar Scheel‐Toellner

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Scheel‐Toellner. A scholar is included among the top collaborators of Dagmar Scheel‐Toellner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Scheel‐Toellner. Dagmar Scheel‐Toellner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of age‐associated B cells in early drug‐naïve rheumatoid arthritis patients 2022 ·Immunology ·(unknown), Najib Naamane, James A. Cameron, Arthur G. Pratt, Andrew L. Mellor, John D. Isaacs, Dagmar Scheel‐Toellner, Amy E. Anderson	21
2	Peripheral blood mononuclear cells preferentially activate 11-oxygenated androgens 2021 ·European Journal of Endocrinology ·Lina Schiffer, (unknown), Punith Kempegowda, Angela E. Taylor, İldem Akerman, Dagmar Scheel‐Toellner, Karl‐Heinz Storbeck, Wiebke Arlt	14
3	B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2017 ·Journal of Autoimmunity ·Khaled Amara, (unknown), Lorraine Yeo, Daniel Ramsköld, Júlia Spengler, Natalie Sippl, James A. Cameron, Lena Israelsson, Philip J. Titcombe, Caroline Grönwall, Ilfita Sahbudin, Andrew Filer, Karim Raza, Vivianne Malmström, Dagmar Scheel‐Toellner	45
4	Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis 2017 ·Journal of Autoimmunity ·Caroline Grönwall, Khaled Amara, (unknown), Akilan Krishnamurthy, Johanna Stéen, Marianne Engström, Meng Sun, A. Jimmy Ytterberg, Roman A. Zubarev, Dagmar Scheel‐Toellner, Jeffrey D. Greenberg, Lars Klareskog, Anca I. Catrina, Vivianne Malmström, Gregg J. Silverman	49
5	Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis 2015 ·Arthritis Research & Therapy ·Dominika E. Nanus, Andrew Filer, Lorraine Yeo, Dagmar Scheel‐Toellner, Rowan Hardy, Gareth G. Lavery, Paul M. Stewart, Christopher D. Buckley, Jeremy Tomlinson, Mark S. Cooper, Karim Raza	12
6	Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes 2014 ·Lara D. Veeken ·Patricia López, Dagmar Scheel‐Toellner, Javier Rodríguez‐Carrio, Luis Caminal‐Montero, Caroline Gordon, Ana Suárez	41
7	Lactoferrin inhibits neutrophil apoptosis via blockade of proximal apoptotic signaling events 2011 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Nigel Francis, See Heng Wong, Peter Hampson, Keqing Wang, Stephen P. Young, Hans P. Deigner, M Salmon, Dagmar Scheel‐Toellner, Janet M. Lord	26
8	Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death 2011 ·Investigational New Drugs ·Agata M. Wasik, Michael Gandy, Matthew J. McIldowie, Michelle J. Holder, Anita Chamba, (unknown), (unknown), Stephen P. Young, Dagmar Scheel‐Toellner, Martin J.S. Dyer, Nicholas M. Barnes, Matthew Piggott, John Gordon	5
9	The response of T cells to interleukin‐6 is differentially regulated by the microenvironment of the rheumatoid synovial fluid and tissue 2011 ·Arthritis & Rheumatism ·(unknown), Sarah Essex, Lorraine Yeo, John Curnow, Andrew Filer, Mark S. Cooper, Andrew Thomas, Helen M. McGettrick, M Salmon, Christopher D. Buckley, Karim Raza, Dagmar Scheel‐Toellner	14
10	Novel Antileukemic Compound Ingenol 3-Angelate Inhibits T Cell Apoptosis by Activating Protein Kinase Cθ 2010 ·Journal of Biological Chemistry ·Wing-Yiu Jason Lee, Peter Hampson, Lydia Coulthard, Farrah Ali, Mike Salmon, Janet M. Lord, Dagmar Scheel‐Toellner	18
11	Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression 2010 ·Arthritis Research & Therapy ·Leigh D Church, Andrew Filer, (unknown), Katherine Howlett, Andrew Thomas, Stephen Rapecki, Dagmar Scheel‐Toellner, Christopher D. Buckley, Karim Raza	24
12	Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis 2006 ·Arthritis Research & Therapy ·Karim Raza, Dagmar Scheel‐Toellner, (unknown), Darrell Pilling, John Curnow, Francesco Falciani, Víctor Treviño, Kanta Kumar, Lakhvir K. Assi, Janet M. Lord, Caroline Gordon, Christopher D. Buckley, Mike Salmon	72
13	Inhibition of T Cell Apoptosis in the Aqueous Humor of Patients with Uveitis by IL-6/Soluble IL-6 Receptor trans -Signaling 2004 ·The Journal of Immunology ·John Curnow, Dagmar Scheel‐Toellner, (unknown), Karim Raza, Omar M. Durrani, Jeff Faint, Saaeha Rauz, Kaska Wloka, Darrell Pilling, Stefan Rose‐John, Christopher D. Buckley, Philip I. Murray, Mike Salmon	88
14	Inhibition of Neutrophil Apoptosis by Type 1 IFN Depends on Cross-Talk Between Phosphoinositol 3-Kinase, Protein Kinase C-δ, and NF-κB Signaling Pathways 2003 ·The Journal of Immunology ·(unknown), Dagmar Scheel‐Toellner, See Heng Wong, Rachel Craddock, Jorge Caamaño, Arne N. Akbar, Mike Salmon, Janet M. Lord	79
15	Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation breakdown → 2001 ·Trends in Immunology ·Christopher D. Buckley, Darrell Pilling, Janet M. Lord, Arne N. Akbar, Dagmar Scheel‐Toellner, (unknown)	559
16	Type 1 IFN Maintains the Survival of Anergic CD4+ T Cells 2000 ·The Journal of Immunology ·Giovanna Lombardi, Pádraic J. Dunne, Dagmar Scheel‐Toellner, (unknown), Darrell Pilling, Leonie S. Taams, Paul Life, Janet M. Lord, Mike Salmon, Arne N. Akbar	40
17	Persistent Induction of the Chemokine Receptor CXCR4 by TGF-β1 on Synovial T Cells Contributes to Their Accumulation Within the Rheumatoid Synovium 2000 ·The Journal of Immunology ·Christopher D. Buckley, Nicole Amft, Paul F. Bradfield, Darrell Pilling, Ewan A. Ross, Fernando Arenzana‐Seisdedos, Ali Amara, John Curnow, Janet M. Lord, Dagmar Scheel‐Toellner, Mike Salmon	275
18	Serine/Threonine Protein Kinases and Apoptosis breakdown → 2000 ·Experimental Cell Research ·(unknown), Dagmar Scheel‐Toellner, N. Henriquez, Elizabeth M. Deacon, Mike Salmon, Janet M. Lord	606
19	RGD peptides induce apoptosis by direct caspase-3 activation 1999 ·Nature ·Christopher D. Buckley, Darrell Pilling, N. Henriquez, Greg Parsonage, (unknown), Dagmar Scheel‐Toellner, David L. Simmons, Arne N. Akbar, Janet M. Lord, Mike Salmon	381
20	Inhibition of T cell apoptosis by IFN-β rapidly reverses nuclear translocation of protein kinase C-δ 1999 ·European Journal of Immunology ·Dagmar Scheel‐Toellner, Darrell Pilling, Arne N. Akbar, Deborah Hardie, Giovanna Lombardi, Mike Salmon, Janet M. Lord	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact